Anteilseigner
Fidelity Management & Research Co. LLC (15,00 %) The Vanguard Group, Inc. (8,60 %) BlackRock Fund Advisors (6,60 %) T. Rowe Price Associates, Inc. (Investment Management) (5,46 %) Deep Track Capital LP (4,72 %) Boxer Capital LLC (4,64 %) Bain Capital Life Sciences LP (4,18 %) Marshall Wace LLP (4,02 %) SSgA Funds Management, Inc. (4,01 %) Lord, Abbett & Co. LLC (3,14 %) Perceptive Advisors LLC (3,07 %) Maverick Capital Ltd. (2,59 %) ArrowMark Colorado Holdings LLC (2,33 %) OrbiMed Advisors Private Equity (2,31 %) Pictet Asset Management SA (2,19 %) Geode Capital Management LLC (2,04 %) Point72 Asset Management LP (2,02 %) Invus Public Equities Advisors LLC (1,92 %) Deerfield Management Co. LP (Private Equity) (1,74 %) Fiera Capital Corp. (Investment Management) (1,24 %)
Kontakt
SpringWorks Therapeutics Inc.